期刊文献+

ANO1在口腔鳞癌中的表达及临床分析 被引量:2

Clinical significance and expression of ANO1 in oral squamous cell carcinoma
下载PDF
导出
摘要 目的探讨ANO1基因及蛋白在口腔鳞癌中的表达及其临床意义。方法用免疫组化SP法及Northern blot检测81例口腔鳞癌组织及相应正常组织的ANO1基因及蛋白的表达,并结合临床病理资料作相关分析。结果 ANO1在口腔鳞癌组织中的阳性表达明显高于正常组织(P<0.05);有淋巴结转移的口腔鳞癌组织ANO1阳性表达高于无转移的口腔鳞癌组织(P<0.05);随着口腔鳞癌临床分期的升高,ANO1的阳性表达率升高(P<0.05)。SCC-25细胞系的内源性ANO1表达31.57±5.31高于Hep-2的0.26±0.03(P<0.05)。SCC-25的侵袭能力明显强于Hep-2(P<0.05)。结论 ANO1可能在口腔鳞癌的发生和发展过程中起到重要作用。 Objective To study the clinical significance of ANO1 mRNA and protein in oral squamous cell carcinoma(OSCC).Methods The specimens of 81 patients with OSCC were examined by SP immunohistochemistry and northern blot.The expression of ANO1 protein,the clinical and pathological feature were analyzed.The expression of ANO1 protein in head and neck cancer cell lines were examined by western blot.Results ANO1 mRNA and protein expression were significantly higher in OSCC than those in normal oral tissue(P0.05),showed significant correlation with clinical stage of OSCC(P0.05) and lymph node metastasis(P0.05).The more endogenous ANO1 was expressed in SCC-25 cell line than in Hep-2 cell line(P0.05).The invasion of SCC-25 was significantly stronger than Hep-2(P0.05).Conclusions ANO1 may be involved in the occurrence,metastasis and progress of OSCC.Analysis of the expression characteristics of ANO1 and its clinical features of OSCC may lead to clinical therapy of OSCC with improved outcome.
出处 《基础医学与临床》 CSCD 北大核心 2012年第10期1175-1178,共4页 Basic and Clinical Medicine
基金 重庆市卫生局2011年医学科研计划项目(面上项目)资助(2011-2-013) 重庆市科委自然科学基金计划(CSTC2012JJA10039)
关键词 口腔鳞癌 ANO1基因 NORTHERN BLOT oral cancer ANO1 gene Northern blot
  • 相关文献

参考文献10

  • 1Shrime MG, Ma C, Gullane PJ, et al. Impact of nodal ratio on survival in squamous cell carcinoma of the oral cavity [J]. Head Neck, 2009,31:1129 - 1136.
  • 2Davis SJ, Divi V, Owen JH, et al. Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma [J]. Arch Otolaryngol Head Neck Surg, 2010,136:1260 - 1266.
  • 3周智恩,李汉忠.C-MYC和LPL基因与前列腺癌的研究进展[J].基础医学与临床,2011,31(10):1181-1184. 被引量:1
  • 4赵林,张才全,廖刚,龙结根,汤为学.PDGF-D和VEGF在胃癌中的表达及其意义[J].基础医学与临床,2009,29(12):1305-1309. 被引量:11
  • 5李雅冬,Ali Gowhere,洪苏玲.人类头颈鳞癌基因组单核苷酸多态性与肿瘤转移的关系[J].第二军医大学学报,2011,32(7):713-716. 被引量:5
  • 6Rickman DS, Millon R, De Reynies A, et al. Prediction of future metastasis and molecular characterization of head and neck squamous cell carcinoma based on transcriptome and genome analysis by microarrays [ J ]. Oncogene, 2008,27 : 6607 - 6622.
  • 7Hartzell H, Yu K, Xiao Q, et al. Anoctamin/TMEM16 family members are Ca^2+-activated C1-channels [ J ]. J Physiol, 2009,587:2127 - 2139.
  • 8Antonella C, Emanuela C, Loretta F,et al. TMEM16A, A membrane protein associated with calcium-dependent chlo- ride channel activity [ J ]. Science, 2008,322:590 - 594.
  • 9Yang YD, Cho H, Koo JY, et al. TMEM16A confers recep- toractivated calcium-dependent chloride conductance [ J ]. Nature,2008,455 : 1210 - 1215.
  • 10Schroeder B, Cheng T, Jan Y, et al. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit [ J ]. Ce11,2008,134 : 1019 - 1029.

二级参考文献29

  • 1张玉英,丰义宽,李国庆,张居民,孙善明.黏蛋白和血管内皮生长因子在胃癌及癌前病变中的表达及意义[J].中华消化杂志,2005,25(10):628-629. 被引量:2
  • 2曾瑄,武莎斐,许群,肖雨,刘彤华.前列腺癌8号染色体改变与Gleason评分之间的相关性[J].中华病理学杂志,2006,35(9):523-528. 被引量:5
  • 3LaRochelle WJ, Jeffers M, Corvalan JR, et al. Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer[ J]. Cancer Res, 2002, 62 (9) : 2468 - 2473.
  • 4Ustach CV, Taube ME, Hurst NJ Jr, et al. A potential oncogenic activity of platelet-derived growth factor D in prostate cancer progression [ J ]. Cancer Res, 2004, 64 ( 5 ) : 1722 - 1729.
  • 5Alakus H, Grass G, Hennecken JK, et al. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer [ J ]. Histol Histopathol, 2008, 23 ( 8 ) : 917 -923.
  • 6Bergsten E, Uutela M, I,i X, et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor [ J ]. Nat Cell Biol, 2001, 3(5) :512 -516.
  • 7Ustach CV, Kim HR. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells [ J ]. Mol Cell Biol, 2005, 25 ( 14 ) : 6279 - 6288.
  • 8Ammoun S, Flaiz C, Ristic N, et al. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma[J]. Cancer Res, 2008, 68( 13): 5236 - 5245.
  • 9Kong Dejuan, Wang Zhiwei,Sarkar SH, et al. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells[ J]. Stem Cells, 2008, 26(6):1425- 1435.
  • 10Wang Zhiwei, Kong Dejuan, Banerjee S, et al. Down-regulation of platelet derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and Nuclear Factor-KB Signaling[ J]. Cancer Res, 2007, 67(23) :11377 - 11385.

共引文献14

同被引文献7

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部